Address
Email address
https://neumedpro.deHOME - Neuwirth Medical Products GmbHIhr Experte für Schlafdiagnostik und Therapie – innovative Lösungen für besseren Schlaf. Entdecken Sie unsere Produkte!
Name
Neuwirth Medical Products Europe OÜ
Registry code
14654550
Type
OÜ - Limited Liability Company
Status
In liquidation
Foundation date
04.02.2019 (5)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Josef Schäfer 13.12.1952 (71) | 30% - 750.00 EUR | - | Direct ownership | Founder |
| Maurice Neuwirth 01.02.1990 (34) | 70% - 1 750.00 EUR | - | Direct ownership | Founder |
| Ville Pärn 22.05.1982 (42) | - | Liquidator | - |
| 2019 16.03.2020 | 2020 08.03.2021 | 2021 05.04.2022 | 2022 30.06.2023 | |
|---|---|---|---|---|
| Total Revenue | 57 899 € | 1 365 596 € | 1 303 959 € | 373 777 € |
| Net profit (loss) for the period | 36 387 € | 186 141 € | 277 383 € | 49 488 € |
| Profit Margin | 63% | 14% | 21% | 13% |
| Current Assets | 50 580 € | 282 665 € | 403 034 € | 131 183 € |
| Fixed Assets | - | - | - | - |
| Total Assets | 50 580 € | 282 665 € | 403 034 € | 131 183 € |
| Current Liabilities | 14 193 € | 89 636 € | 81 515 € | 8 166 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 36 387 € | 193 029 € | 321 519 € | 123 017 € |
| Employees | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 14.8 € | - | - |
| 2023 Q4 | 8 393.74 € | - | - | - |
| 2023 Q3 | 34.62 € | 25 606.98 € | 7 700 € | - |
| 2023 Q2 | 16 027.4 € | - | - | - |
| 2023 Q1 | 52 768.9 € | - | - | - |
| 2022 Q4 | 16 596 € | - | - | - |
| 2022 Q3 | 16 610.33 € | 55.5 € | - | - |
| 2022 Q2 | 67 662.71 € | 62 161.96 € | 4 203.43 € | - |
| 2022 Q1 | 76 230.36 € | 3 € | - | - |
| 2021 Q4 | 89 857.97 € | - | - | - |
| 2021 Q3 | 91 368 € | 928.57 € | - | - |
| 2021 Q2 | 108 881.8 € | 37 074.48 € | 746.67 € | - |
| 2021 Q1 | 74 605.79 € | - | - | 1 |
| 2020 Q4 | 88 006.1 € | 1 593.18 € | 1 593.18 € | 1 |
| 2020 Q3 | 74 979.25 € | - | - | 1 |
| 2020 Q2 | 23 429 € | 8 008.75 € | - | 1 |
| 2020 Q1 | 33 034 € | 6 625.32 € | 6 625 € | 1 |
